Single-port vs multi-port robotic surgery for prostate or kidney cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two types of robot-assisted surgery for treating prostate or kidney cancer. It aims to see if a single-port approach (through one small incision) is as safe and effective as the standard multi-port approach (through several small incisions), potentially offering faster recovery and less pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with prostate cancer (if you are a man) or kidney cancer (for men or women).
- Your imaging tests (like CT or PSMA PET) show no signs that the cancer has spread to distant organs.
- You are considered a suitable candidate for one of the two surgical procedures being studied.
- You are able to give written informed consent and follow the study protocol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether robot-assisted surgery can be a safe and effective way to treat early-stage prostate or kidney cancer. If you are eligible, it could give you access to a less invasive surgical option.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This study is testing a special technique in robot-assisted kidney surgery where the blood supply to the kidney is not clamped and the tumor is removed without sutures. It may reduce damage to healthy kidney tissue and speed recovery.
This trial tests whether using a combined PSMA-PET/MRI and ultrasound navigation system during robot-assisted prostate removal can help the surgeon remove the cancer more completely while preserving surrounding tissue. It is for patients with early-stage prostate cancer that is just starting to spread outside the prostate.
This study compares a robot-assisted kidney-sparing surgery guided by 3D images. It aims to improve how precisely surgeons remove a complex kidney tumor while protecting kidney function.
This trial compares different robotic platforms used to remove kidney tumors while saving healthy kidney tissue. It aims to see which system works best for patients with localized kidney tumors.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.